Madrigal Pharmaceuticals
(NASDAQ) MDGL
Madrigal Pharmaceuticals Financials at a Glance
Market Cap
$10.21B
Revenue (TTM)
$958.40M
Net Income (TTM)
$288.28M
EPS (TTM)
$-12.86
P/E Ratio
-34.60
Dividend
$0.00
Beta (Volatility)
0.95 (Low)
Dividend
$0.00
Beta (Volatility)
0.95 (Low)
Price
$459.98
Volume
1,859
Open
$448.76
Price
$459.98
Volume
1,859
Open
$448.76
Previous Close
$445.04
Daily Range
$448.76 - $458.61
52-Week Range
$265.00 - $615.00
Dividend
$0.00
Beta (Volatility)
0.95 (Low)
Price
$459.98
Volume
1,859
Open
$448.76
Previous Close
$445.04
Daily Range
$448.76 - $458.61
52-Week Range
$265.00 - $615.00
MDGL News
MDGL: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Madrigal Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
915
CEO
William J. Sibold, MBA
Website
www.madrigalpharma.comHeadquarters
West Conshohocken, PA 19428, US
MDGL Financials
Key Financial Metrics (TTM)
Gross Margin
94%
Operating Margin
-31%
Net Income Margin
-30%
Return on Equity
-42%
Return on Capital
-32%
Return on Assets
-23%
Earnings Yield
-2.89%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$10.21B
Shares Outstanding
22.94M
Volume
1.86K
Short Interest
0.00%
Avg. Volume
345.07K
Financials (TTM)
Gross Profit
$902.25M
Operating Income
$300.10M
EBITDA
$264.47M
Operating Cash Flow
$189.55M
Capital Expenditure
$467.00K
Free Cash Flow
$190.02M
Cash & ST Invst.
$983.56M
Total Debt
$354.36M
Madrigal Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$321.08M
+210.8%
Gross Profit
$296.63M
+197.0%
Gross Margin
92.39%
N/A
Market Cap
$10.21B
N/A
Market Cap/Employee
$19.34M
N/A
Employees
528
N/A
Net Income
$58.58M
+1.4%
EBITDA
$49.89M
+10.2%
Quarterly Fundamentals
Net Cash
$629.20M
-22.0%
Accounts Receivable
$134.48M
+149.9%
Inventory
$74.84M
+119.7%
Long Term Debt
$353.34M
+198.0%
Short Term Debt
$1.02M
+3.6%
Return on Assets
-22.89%
N/A
Return on Invested Capital
-31.61%
N/A
Free Cash Flow
$133.07M
-27.1%
Operating Cash Flow
$133.46M
-27.7%